ESR1, PGR, ERBB2, and MKi67 mRNA expression in postmenopausal women with hormone receptor-positive early breast cancer: results from ABCSG Trial 6
Martin Filipits(University of Vienna), Peter Dubsky(Hirslanden Klinik St. Anna), Zsuzsanna Bagó-Horváth(Comprehensive Cancer Center Vienna), Florian Fitzal, Michael Gnant(Austrian Breast & Colorectal Cancer Study Group), Richard Greil(Paracelsus Medical University), Jodi Weidler, Sigurd Lax(Graz University Hospital), Wolfgang Hulla(Fachhochschule Wiener Neustadt), Margaretha Rudas(Comprehensive Cancer Center Vienna), X. Liu, Marija Balić(University of Pittsburgh), Natalie Wu, Stacey Halper(Fachhochschule Wiener Neustadt), Dominik Hlauschek(Austrian Breast & Colorectal Cancer Study Group), Michael Bates, Christian F. Singer(Comprehensive Cancer Center Vienna)
Cited by 25
Related Papers
Breast cancer
|Nature Reviews Disease Primers|2019|2.9k
Breast cancer
|The Lancet|2016|2.3k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.4k
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer
|Annals of Oncology|2021|1.4k